Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9626 posts found.

British biotech: rebuilding momentum

May 26, 2011 Research and Development UK, biotech, biotech funding

Since biotech first emerged in the UK in the late 1980s, the dream has always been for the country to …
Feature

Elan signs $20m research deal with Proteostasis

May 25, 2011 Research and Development Elan, Proteostasis, neurodegenerative diseases

Elan Corporation has signed a deal with US small molecule drug specialist Proteostasis Therapeutics to develop products for conditions such …
News

Eisai extends neuroscience partnership with UCL

May 25, 2011 Research and Development Eisai, UCL, academic alliance, academic research, neurodegenerative diseases

Eisai and University College London are to extend their partnership in neuroscience research. The Japanese company’s Neuroscience Product Creation Unit …
News

Contract research news in brief

May 25, 2011 Research and Development contract research, contract research news

Mergers and acquisitions abound in our latest round-up of contract research sector news, as players try to achieve the global …
News
GlaxoSmithKline

GSK takes lead role in UK personalised medicine programme

May 20, 2011 Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine

The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …
News

Pfizer’s cancer drug meets end points in head-to-head study

May 20, 2011 Research and Development, Sales and Marketing Pfizer, axitinib, rcc

Pfizer’s investigational cancer drug axitinib significantly increased survival in kidney cancer patients when compared to Bayer’s standard treatment Nexavar. New …
News

Blood cancer charity to kick-start clinical trials

May 19, 2011 Research and Development Cancer, blood cancer, clinical trials, leukaemia

A UK blood cancer charity is creating a network of clinical trial centres with backing from the NIHR Clinical Research …
News
Roche

MetMab produces exciting results in lung cancer patients

May 19, 2011 Research and Development MetMAb, Roche

Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …
News
Takeda headquarters

Takeda buys Nycomed for $13.6bn

May 19, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Nycomed, Takeda

Takeda has acquired Swiss specialist pharma firm Nycomed, boosting its presence in emerging markets. The deal comes in at 9.6 …
News
Shire UK

Shire makes $750m regenerative medicines acquisition

May 18, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Shire, regenerative medicine

Shire’s ambitions to build a regenerative medicine business will soon be realised following its $750 million acquisition of Advanced BioHealing. …
News

Mark Dean-Netscher joins Penn Pharma

May 18, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Penn Pharma has appointed Mark Dean-Netscher as its new chief operating officer. He has more than 20 years experience in …
Appointment

Sanofi strikes Crohn’s deal with Glenmark

May 16, 2011 Research and Development Crohn’s disease, Glenmark, Sanofi

Sanofi has signed a deal with Indian drug maker Glenmark Pharmaceuticals to develop a new treatment for Crohn’s Disease. The …
News
ABPI's London offices

ABPI and BIA move in together

May 16, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA

The UK’s pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. …
News

It’s time we redesigned the clinical trial

May 16, 2011 Research and Development clinical trials, randomised controlled trials

Who can remember a time when the pathway from laboratory bench to marketed product didn’t include clinical trial phases I …
Feature

Takeda denies $12bn Nycomed takeover reports

May 13, 2011 Research and Development, Sales and Marketing Nycomed, Takeda

Japan’s biggest pharma firm Takeda has denied reports it is negotiating a billion dollar deal to acquire Swiss speciality firm …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026